On Monday, Astera Labs ALAB got an upgrade for its IBD SmartSelect Composite Rating from 92 to 96. Please watch the video at ...

HC Wainwright upgraded Shattuck Labs Inc. (NASDAQ: STTK) from Neutral to Buy, with a price forecast of $6. The company’s lead product candidate, SL-325, is a DR3 antagonist antibody for inflammatory ...

– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The ...

Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...

Shattuck Labs Inc. has announced a strategic shift to focus on SL-325, a death receptor 3 (DR3) antagonist antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory ...

Inflammatory bowel disease (IBD) is a chronic condition that currently does not have a cure. However, certain lifestyle measures, such as keeping an IBD journal, can help you track symptoms, identify ...

A new study shows stimulating the vagus nerve in mice with colitis reduced stress-driven symptoms of inflammatory bowel disease by regulating SUMOylation, an immune response that triggers gut ...

In inflammatory bowel disease (IBD), the gastrointestinal (GI) tract is chronically inflamed, and the term may refer to either Crohn’s disease or ulcerative colitis. This chronic inflammation can lead ...

Inflammatory bowel disease (IBD) during pregnancy can lead to complications for individuals who are pregnant and the fetus. Timing conception during remission and preventing or managing flare-ups can ...